GERMANY - Dresden Fonds GmbH sells stake in nAmbition GmbH
Dresden Fonds GmbH, jointly managed by CFH GmbH and SIB GmbH, has sold all stakes of nAmbition GmbH to strategic investor JPK Instruments AG, for an undisclosed sum. Dresden Fonds realised a double digit IRR from the sale. nAmbition develops solutions and methods for the nanobiotechnolgy industry, is based in Dresden, and employs a staff of 12.
More on Exits
Five Arrows kicks off Laf Santé sale
Five Arrows has owned a majority stake in the France-based low-cost pharmacy chain since 2016
Hg’s MEDIFOX sale launch draws large-cap sponsor interest
Hg acquired the software platform for care providers in 2018 from ECM Equity Capital Management
Sovereign Capital readies Nurse Plus for exit
Clearwater International hired to advise on sale of the UK-based healthcare staff agency
Perusa to exit Müpro in SBO to IK
Management of the German industrial fixings supplier will reinvest with a minority stake
Latest News
FSN Capital acquires Epista Life Sciences
The GP said it will pursue a buy-and-build strategy in the life science IT services sector
Advent Life Sciences hires three partners
Dominic Schmidt is based in the UK, while Satish Jindal and Katrine Bosley join in the US
Five Arrows kicks off Laf Santé sale
Five Arrows has owned a majority stake in the France-based low-cost pharmacy chain since 2016
Hg’s MEDIFOX sale launch draws large-cap sponsor interest
Hg acquired the software platform for care providers in 2018 from ECM Equity Capital Management